Cytokinetics, Incorporated (NASDAQ:CYTK): Current price $1.07
On Thursday, the firm received a notice from Nasdaq confirming that for the last 10 consecutive business days, the closing bid price of the Company’s common stock has been at $1 per share or higher, and thus the firm has regained compliance with Listing Rule 5450a(1). On June 18, 2012. the company’s common stock had failed to maintain the minimum bid price over the previous 30 consecutive business days, as required by the Listing Rules of the Nasdaq Stock Market.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.